摘要:中国创新药产业趋势已成,进军全球商业化立足现在:进军全球商业化,大量优质项目将继续推高产业发展中国创新药行业已形成以领头企业为引领、大批量优质企业为支撑的金字塔梯队,产业兑现持续性强。我们认为这一轮周期的底层逻辑是中国在研创新药具备全球竞争力,兑现形式由在中国销售放量转向国际化的数据与交易兑现(license out BD),商业化空间打开,生态更趋健康成熟,逐步迈入产品与商业模式的双轮驱动...
Source Link摘要:中国创新药产业趋势已成,进军全球商业化立足现在:进军全球商业化,大量优质项目将继续推高产业发展中国创新药行业已形成以领头企业为引领、大批量优质企业为支撑的金字塔梯队,产业兑现持续性强。我们认为这一轮周期的底层逻辑是中国在研创新药具备全球竞争力,兑现形式由在中国销售放量转向国际化的数据与交易兑现(license out BD),商业化空间打开,生态更趋健康成熟,逐步迈入产品与商业模式的双轮驱动...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.